(Q36642170)

English

A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

scientific article published on August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kollmannsberger C

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Quietzsch D

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Haag C

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Lingenfelser T

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Schroeder M

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Hartmann JT

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Baronius W

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Hempel V

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Clemens M

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kanz L

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Bokemeyer C

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

83

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

458-462

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Phase II study of paclitaxel in pretreated advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

The treatment of advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Chemotherapy of carcinoma of the stomach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Taxol: a novel investigational antimicrotubule agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

30 September 2017

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

28 June 2018

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

28 June 2018

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

28 June 2018

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

20 September 2018

Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374647

20 September 2018

Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for Advanced Gastric Cancer: Focus on New Agents and Combinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin plus continuous infusion of 5-fluorouracil for 5 days effective for patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of Taxol in patients with advanced gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10945491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1295

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36642170&oldid=2199130124"